 |
|
Challenges and innovations in primary sclerosing cholangitis clinical trials: Evaluating HK-660S and the path forward: Editorial on “Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial”
Nilanga Nishad
Clin Mol Hepatol. 2025;31(2):581-583. Published online 2024 Nov 4 DOI: https://doi.org/10.3350/cmh.2024.0942
|
|
Citations to this article as recorded by
 Correspondence to editorial on “Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial”
Woo Hyun Paik, Do Hyun Park
Clinical and Molecular Hepatology.2025; 31(2): e158. CrossRef
|